Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrew C Perkins Jean-Jacques Kiladjian Peter Ganly Adam J Mead |
| Publication date | March 20, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |